Yinbo Chen, n/a

Bristol Myers Squibb

Poster(s):

• (M-013) QSP Model of Nivolumab in Combination with Bispecific T Cell Engagers predicts Enhanced Anti-Tumor Immunity
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT